Financial News
Icon Plc (NQ: ICLR )
324.16
+3.84
(+1.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Icon Plc
![](https://investorplace.com/wp-content/uploads/2019/10/generation-z-stocks-1600.jpg)
![](https://mms.businesswire.com/media/20240226994125/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at Upcoming Investor Conferences
February 26, 2024
From ICON plc
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Here's How Much $1000 Invested In Icon 20 Years Ago Would Be Worth Today
February 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Icon
October 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where Icon Stands With Analysts
September 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/22/image_3.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240221492475/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Reports Fourth Quarter and Full Year 2023 Results
February 21, 2024
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20240130751222/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20240124995130/en/2007946/5/ICON_logo_high_res.jpg)
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
January 24, 2024
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20240109333358/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240108742855/en/1991802/5/ICON_logo_high_res.jpg)
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
January 08, 2024
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20240104297734/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20231218732293/en/1973261/5/ICON_logo_high_res.jpg)
![](https://mms.businesswire.com/media/20231207194275/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
December 07, 2023
From ICON plc
Via Business Wire
![](https://g.foolcdn.com/editorial/images/754664/investing-screen-analysis-investor-growth-stocks.jpg)
![](https://mms.businesswire.com/media/20231107047223/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at Upcoming Investor Conferences
November 08, 2023
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20231025382191/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/17/lennox_international_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231012433612/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Secures Upgraded Credit Rating from S&P Global Ratings
October 12, 2023
From ICON plc
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2023/09/ai_candlestick_graph.png)
3 Publicly Traded Companies Most at Risk of an AI Smackdown
September 28, 2023
Via InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://mms.businesswire.com/media/20230921148039/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
September 21, 2023
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20230920888786/en/1895055/5/ICON_logo_high_res.jpg)
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
September 20, 2023
From ICON plc
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/09/14/uber_-logo.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230913208048/en/1889056/5/ICON_logo_alg_green.jpg)
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
September 13, 2023
From ICON plc
Via Business Wire
![](https://mms.businesswire.com/media/20230906124201/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at the Baird Global Healthcare Conference
September 06, 2023
From ICON plc
Via Business Wire
ICON PLC (NASDAQ: ICLR) Climbs to New 52-Week High
August 15, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.